mProX™ Human TRPM2 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Ion Channel Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Amanda
Verified Customer
Cynthia
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 TRPM2 levels in breast cell lines and knockdown of TRPM2 levels by RNAi silencing.
Immunoblot analysis of the levels of the protein TRPM2 in two malignant and two non-cancerous breast cell lines (MCF-7, MDA-MB-231) and HMEC, MCF-10A. The positive control was the quantity of TRPM2 protein detected by immunoblot analysis in human embryonic kidney cells (HEK 293).
Ref: Hopkins, Mandi M., et al. "Inhibition of the transient receptor potential melastatin-2 channel causes increased DNA damage and decreased proliferation in breast adenocarcinoma cells." International journal of oncology 46.5 (2015): 2267-2276.
Pubmed: 25760245
DOI: 10.3892/ijo.2015.2919
Research Highlights
TRPM2, also known as transient receptor potential melastatin 2, is a cation channel linked to a number of illnesses. Adenosine diphosphate (ADP)-ribose (ADPR) is bound by its C-terminal NUDT9 homology (NUDT9H) domain, and TRPM2 activation requires both ADPR and Ca2+.
Wang, Longfei, et al. "Structures and gating mechanism of human TRPM2." Science 362.6421 (2018): eaav4809.
Pubmed:
30467180
DOI:
10.1126/science.aav4809
The activity of TRP-melastatin 2 (TRPM2), which is dependent on intracellular calcium (Ca2+), is specifically engaged in the response to oxidative stress and inflammation. Through the control of various signaling pathways, TRPM2 is involved in a number of physiological and pathological processes in the brain.
Sita, Giulia, et al. "TRPM2 in the brain: role in health and disease." Cells 7.7 (2018): 82.
Pubmed:
30037128
DOI:
10.3390/cells7070082